ATE401057T1 - Verfahren zur einführung eines lipid-verknüpften teils in eine vorgeformte lipidanordnung mit mikrowellen - Google Patents
Verfahren zur einführung eines lipid-verknüpften teils in eine vorgeformte lipidanordnung mit mikrowellenInfo
- Publication number
- ATE401057T1 ATE401057T1 AT05807394T AT05807394T ATE401057T1 AT E401057 T1 ATE401057 T1 AT E401057T1 AT 05807394 T AT05807394 T AT 05807394T AT 05807394 T AT05807394 T AT 05807394T AT E401057 T1 ATE401057 T1 AT E401057T1
- Authority
- AT
- Austria
- Prior art keywords
- lipid
- linked moiety
- microwaves
- introducing
- assembly
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6907—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a microemulsion, nanoemulsion or micelle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
- A61K47/6913—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome the liposome being modified on its surface by an antibody
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Nanotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61750504P | 2004-10-08 | 2004-10-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE401057T1 true ATE401057T1 (de) | 2008-08-15 |
Family
ID=35617473
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05807394T ATE401057T1 (de) | 2004-10-08 | 2005-10-07 | Verfahren zur einführung eines lipid-verknüpften teils in eine vorgeformte lipidanordnung mit mikrowellen |
Country Status (8)
Country | Link |
---|---|
US (1) | US7985417B2 (de) |
EP (1) | EP1809246B1 (de) |
JP (1) | JP2008515929A (de) |
AT (1) | ATE401057T1 (de) |
AU (1) | AU2005295072A1 (de) |
CA (1) | CA2582242A1 (de) |
DE (1) | DE602005008270D1 (de) |
WO (1) | WO2006042270A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2004233873B2 (en) | 2003-04-25 | 2010-11-18 | The Penn State Research Foundation | Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds |
US9393315B2 (en) | 2011-06-08 | 2016-07-19 | Nitto Denko Corporation | Compounds for targeting drug delivery and enhancing siRNA activity |
EP2142167A2 (de) * | 2007-03-30 | 2010-01-13 | Epitarget As | Akustisch sensitive wirkstofffreisetzungspartikel |
DE102008050036A1 (de) * | 2007-10-02 | 2009-04-30 | Kuhs Gmbh | Topisch zu applizierende kosmetische oder pharmazeutische Zusammensetzung |
WO2009072136A1 (en) | 2007-12-06 | 2009-06-11 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Particulate drug carriers as desensitizing agents |
US9907746B2 (en) | 2009-07-06 | 2018-03-06 | Variation Biotechnologies, Inc. | Methods for preparing vesicles and formulations produced therefrom |
CA2767392C (en) * | 2009-07-06 | 2017-03-14 | Variation Biotechnologies, Inc. | Methods for preparing vesicles and formulations produced therefrom |
CN103153283B (zh) | 2010-06-19 | 2017-05-17 | 健康科学西部大学 | Peg化脂质体包封的糖肽抗生素的新制剂 |
CA2840079C (en) | 2010-07-06 | 2018-07-03 | Variation Biotechnologies Inc. | Compositions and methods for treating influenza |
WO2012097346A1 (en) | 2011-01-13 | 2012-07-19 | Variation Biotechnologies, Inc. | Compositions and methods for treating viral infections |
CN103796668B (zh) * | 2011-09-28 | 2016-12-28 | 泰尔茂株式会社 | 含有血红蛋白的脂质体及其制造方法 |
EP2802353A4 (de) | 2012-01-12 | 2015-12-02 | Variation Biotechnologies Inc | Zusammensetzungen und verfahren zur behandlung von virusinfektionen |
US20150079077A1 (en) | 2012-01-27 | 2015-03-19 | Variation Biotechnologies, Inc. | Methods and compositions for therapeutic agents |
US20140271822A1 (en) * | 2013-03-13 | 2014-09-18 | Mallinckrodt Llc | Modified docetaxel liposome formulations |
GB201612108D0 (en) | 2016-07-12 | 2016-08-24 | Univ Strathclyde | Preperation of non-ionic surfactant vesicles and variants |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5013556A (en) * | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
US5585112A (en) * | 1989-12-22 | 1996-12-17 | Imarx Pharmaceutical Corp. | Method of preparing gas and gaseous precursor-filled microspheres |
IS1685B (is) * | 1990-12-11 | 1998-02-24 | Bracco International B.V. | Aðferð við að búa til fitukúlur (liposomes) sem eru gæddar auknum hæfileika til að draga í sig og halda í sér aðskotaefnum |
US5395619A (en) * | 1993-03-03 | 1995-03-07 | Liposome Technology, Inc. | Lipid-polymer conjugates and liposomes |
US6326353B1 (en) * | 1993-03-23 | 2001-12-04 | Sequus Pharmaceuticals, Inc. | Enhanced circulation effector composition and method |
US6180134B1 (en) * | 1993-03-23 | 2001-01-30 | Sequus Pharmaceuticals, Inc. | Enhanced ciruclation effector composition and method |
SE9403245D0 (sv) * | 1994-09-26 | 1994-09-26 | Pharmacia Biosensor Ab | Improvements relating to bilayer lipid membranes |
US6214388B1 (en) * | 1994-11-09 | 2001-04-10 | The Regents Of The University Of California | Immunoliposomes that optimize internalization into target cells |
US5616790A (en) * | 1994-11-18 | 1997-04-01 | California Institute Of Technology | Lipid-based metal sensor |
TW520297B (en) * | 1996-10-11 | 2003-02-11 | Sequus Pharm Inc | Fusogenic liposome composition and method |
US6056973A (en) * | 1996-10-11 | 2000-05-02 | Sequus Pharmaceuticals, Inc. | Therapeutic liposome composition and method of preparation |
WO1998023948A1 (en) | 1996-11-29 | 1998-06-04 | The Board Of Trustees Of The Leland Stanford Junior University | Arrays of independently-addressable supported fluid bilayer membranes and methods of use thereof |
US7244826B1 (en) | 1998-04-24 | 2007-07-17 | The Regents Of The University Of California | Internalizing ERB2 antibodies |
US7112337B2 (en) * | 1999-04-23 | 2006-09-26 | Alza Corporation | Liposome composition for delivery of nucleic acid |
EP1218097A1 (de) | 1999-10-08 | 2002-07-03 | The Board Of Trustees Of The Leland Stanford Junior University | Doppelschichtige lipidmembranmatrizen und verfahren zu deren herstellung und verwendung |
-
2005
- 2005-10-07 US US11/246,340 patent/US7985417B2/en not_active Expired - Fee Related
- 2005-10-07 CA CA002582242A patent/CA2582242A1/en not_active Abandoned
- 2005-10-07 AU AU2005295072A patent/AU2005295072A1/en not_active Abandoned
- 2005-10-07 DE DE602005008270T patent/DE602005008270D1/de active Active
- 2005-10-07 EP EP05807394A patent/EP1809246B1/de active Active
- 2005-10-07 WO PCT/US2005/036646 patent/WO2006042270A1/en active Application Filing
- 2005-10-07 JP JP2007535913A patent/JP2008515929A/ja active Pending
- 2005-10-07 AT AT05807394T patent/ATE401057T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1809246B1 (de) | 2008-07-16 |
EP1809246A1 (de) | 2007-07-25 |
AU2005295072A1 (en) | 2006-04-20 |
WO2006042270A1 (en) | 2006-04-20 |
CA2582242A1 (en) | 2006-04-20 |
DE602005008270D1 (de) | 2008-08-28 |
US7985417B2 (en) | 2011-07-26 |
US20060121105A1 (en) | 2006-06-08 |
JP2008515929A (ja) | 2008-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE401057T1 (de) | Verfahren zur einführung eines lipid-verknüpften teils in eine vorgeformte lipidanordnung mit mikrowellen | |
DE69837274D1 (de) | Verfahren zur verkapselung von nukleinsäuren in lipiddoppelschichten | |
PT1157041E (pt) | Anticorpos para terapia e diagnostico de cancro | |
DE69616523D1 (de) | Verfahren zur baladung von lipidvesikeln | |
BRPI0113477B8 (pt) | proteína de fusão para distribuição de um peptídeo, proteína, glicoproteína ou oligonucleotídeo em uma célula | |
AR037666A1 (es) | Metodo para la identificacion de enzimas marcadores tumorales | |
Rodallec et al. | Docetaxel–trastuzumab stealth immunoliposome: development and in vitro proof of concept studies in breast cancer | |
WO2001041740A3 (en) | Reconstitution of purified membrane proteins into preformed liposomes | |
DE69838147D1 (de) | Verbindungen und methoden zur modulierung von occludin-abhängiger gewebepermeabilität | |
ATE200679T1 (de) | Neues verfahren zur herstellung von anti-humanen antigenrezeptoren und deren verwendungen | |
BRPI0411519A (pt) | membrana viral reconstituìda, método para produzir uma membrana viral reconstituìda, e, composição farmacêutica | |
BRPI0915142A8 (pt) | Polipeptídeos, ácido nucleico e usos dos mesmos | |
RU2012144392A (ru) | Композиции липидных везикул и способы применения | |
BRPI0608297A2 (pt) | composições de lipossomos | |
BR0115260A (pt) | Complexos de sn-38 com lipìdeos e seus usos no tratamento de doenças | |
EA200100493A1 (ru) | Имплантат с полостями, содержащими лекарственные средства | |
BRPI0415308A (pt) | incorporação especìfica de local de aminoácidos redox ativos em proteìnas | |
DK1633784T3 (da) | OVR110 antistofsammensætninger og -anvendelsesfremgangsmåder | |
NO20055209L (no) | Peptabody for cancerbehandling | |
AR046184A1 (es) | Composicion nutricional en contra de los efectos colaterales de quimioterapia y radioterapia | |
WO2011031497A3 (en) | Quantitative fluorescent protein standards | |
Yotsu-Yamashita et al. | Localization of pufferfish saxitoxin and tetrodotoxin binding protein (PSTBP) in the tissues of the pufferfish, Takifugu pardalis, analyzed by immunohistochemical staining | |
ATE453328T1 (de) | Verbesserte formulierung zur bereitstellung eines magensaftresitenten beschichtungsmaterials | |
MX2008008185A (es) | Antigenos de acido des-n-acetil-sialico, anticuerpos para los mismos, y metodos de uso en la terapia de cancer. | |
WO2001023421A3 (en) | Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |